Literature DB >> 21864074

Chronic cerebrospinal venous insufficiency in multiple sclerosis: diagnostic, pathogenetic, clinical and treatment perspectives.

Robert Zivadinov1, Murali Ramanathan, Kresimir Dolic, Karen Marr, Yuval Karmon, Adnan H Siddiqui, Ralph Hb Benedict, Bianca Weinstock-Guttman.   

Abstract

Chronic cerebrospinal venous insufficiency (CCSVI) was recently described in multiple sclerosis patients. CCSVI is characterized by impaired brain venous drainage due to outflow obstruction in the extracranial venous system, mostly related to anomalies in the internal jugular and azygos veins. The current CCSVI diagnosis is based on Doppler sonography of extracranial and transcranial venous hemodynamics criteria. To date, prevalence estimates of CCSVI, provided by different groups using various imaging methods of assessment, vary widely from none to 100%. There is an urgent need to define and validate the spectrum of cranial/extracranial venous anomalies and to establish reliable, diagnostic gold-standard test(s). The potential usefulness of endovascular treatment for CCSVI in multiple sclerosis patients is still unknown.

Entities:  

Mesh:

Year:  2011        PMID: 21864074     DOI: 10.1586/ern.11.117

Source DB:  PubMed          Journal:  Expert Rev Neurother        ISSN: 1473-7175            Impact factor:   4.618


  17 in total

1.  Chronic cerebrospinal venous insufficiency in multiple sclerosis: a historical perspective.

Authors:  Michael D Dake; Robert Zivadinov; E Mark Haacke
Journal:  Funct Neurol       Date:  2011 Oct-Dec

2.  Percutaneous transluminal angioplasty for treatment of chronic cerebrospinal venous insufficiency (CCSVI) in people with multiple sclerosis.

Authors:  Vanitha A Jagannath; Eugenio Pucci; Govindaraj V Asokan; Edward W Robak
Journal:  Cochrane Database Syst Rev       Date:  2019-05-31

3.  Intra- and extraluminal structural and functional venous anomalies in multiple sclerosis, as evidenced by 2 noninvasive imaging techniques.

Authors:  K Dolic; K Marr; V Valnarov; M G Dwyer; E Carl; Y Karmon; C Kennedy; C Brooks; C Kilanowski; K Hunt; A H Siddiqui; D Hojnacki; B Weinstock-Guttman; R Zivadinov
Journal:  AJNR Am J Neuroradiol       Date:  2011-12-22       Impact factor: 3.825

4.  Jugular Venous Flow Quantification Using Doppler Sonography.

Authors:  Karen Marr; Dejan Jakimovski; Marcello Mancini; Ellen Carl; Robert Zivadinov
Journal:  Ultrasound Med Biol       Date:  2018-05-18       Impact factor: 2.998

5.  Prospective randomized trial of venous angioplasty in MS (PREMiSe).

Authors:  Adnan H Siddiqui; Robert Zivadinov; Ralph H B Benedict; Yuval Karmon; Jihnhee Yu; Mary L Hartney; Karen L Marr; Vesela Valnarov; Cheryl L Kennedy; Murali Ramanathan; Deepa P Ramasamy; Kresimir Dolic; David W Hojnacki; Ellen Carl; Elad I Levy; L Nelson Hopkins; Bianca Weinstock-Guttman
Journal:  Neurology       Date:  2014-06-27       Impact factor: 9.910

6.  No association between conventional brain MR imaging and chronic cerebrospinal venous insufficiency in multiple sclerosis.

Authors:  R Zivadinov; G Cutter; K Marr; M Ramanathan; R H B Benedict; N Bergsland; C Morgan; E Carl; D Hojnacki; E A Yeh; L Willis; M Cherneva; C Kennedy; M G Dwyer; B Weinstock-Guttman
Journal:  AJNR Am J Neuroradiol       Date:  2012-05-10       Impact factor: 3.825

Review 7.  The role of noninvasive and invasive diagnostic imaging techniques for detection of extra-cranial venous system anomalies and developmental variants.

Authors:  Kresimir Dolic; Adnan H Siddiqui; Yuval Karmon; Karen Marr; Robert Zivadinov
Journal:  BMC Med       Date:  2013-06-27       Impact factor: 8.775

8.  Internal jugular vein entrapment in a multiple sclerosis patient.

Authors:  Marian Simka; Eugeniusz Majewski; Marek Fortuna; Maciej Zaniewski
Journal:  Case Rep Surg       Date:  2012-10-11

9.  Theranostic implications of nanotechnology in multiple sclerosis: a future perspective.

Authors:  Ajay Vikram Singh; Manish Khare; W N Gade; Paolo Zamboni
Journal:  Autoimmune Dis       Date:  2012-12-30

10.  Chronic cerebrospinal venous insufficiency is not associated with cognitive impairment in multiple sclerosis.

Authors:  Ralph H B Benedict; Bianca Weinstock-Guttmam; Karen Marr; Vesela Valnarov; Cheryl Kennedy; Ellen Carl; Christina Brooks; David Hojnacki; Robert Zivadinov
Journal:  BMC Med       Date:  2013-07-18       Impact factor: 8.775

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.